MDMA (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "MDMA" in Finnish language version.

refsWebsite

Global rank Finnish rank

50nih.gov

4^th place

12^th place

46doi.org

2^nd place

10^th place

42worldcat.org

5^th place

9^th place

8researchgate.net

120^th place

243^rd place

5sagepub.com

731^st place

767^th place

5maps.org

low place

5,059^th place

4web.archive.org

1^st place

4wiley.com

222^nd place

202^nd place

3springer.com

274^th place

418^th place

2tandfonline.com

507^th place

559^th place

2europa.eu

68^th place

51^st place

2sciencedirect.com

149^th place

237^th place

1finlex.fi

3,070^th place

17^th place

1ajconline.org

low place

1benthamopen.com

low place

1europepmc.org

8,929^th place

low place

1psu.edu

207^th place

1,082^nd place

1jstor.org

26^th place

312^th place

1northwestern.edu

2,302^nd place

9,196^th place

1erowid.org

3,887^th place

839^th place

1apnews.com

129^th place

643^rd place

1findlaw.com

1,478^th place

6,146^th place

1urn.fi

8,035^th place

70^th place

1mapseurope.eu

low place

1globaldrugsurvey.com

low place

1unibas.ch

low place

1asnjournals.org

low place

1mapscontent.s3-us-west-1.amazonaws.com

low place

1aspetjournals.org

6,663^rd place

2,918^th place

1rollsafe.org

low place

1tietopyynto.fi

low place

5,926^th place

ajconline.org (Global: low place; Finnish: low place)

Droogmans, S. ym.: Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease. The American Journal of Cardiology, 2007, 100. vsk, nro 9, s. 1442–1445. PubMed:17950805 doi:10.1016/j.amjcard.2007.06.045 ISSN 0002-9149 Artikkelin verkkoversio. (englanniksi)

apnews.com (Global: 129^th place; Finnish: 643^rd place)

Baker, Kathryn: DEA to ban ”ecstasy” – the drug MDMA apnews.com. 31.5.1986. Arkistoitu 29.11.2020. Viitattu 29.11.2020. (englanniksi)

asnjournals.org (Global: low place; Finnish: low place)

cjasn.asnjournals.org

Campbell, G. A. & Rosner, M. H.: The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Clinical Journal of the American Society of Nephrology, 2008, 3. vsk, nro 6, s. 1852–1860. PubMed:18684895 doi:10.2215/CJN.02080508 ISSN 1555-9041 Artikkelin verkkoversio. (englanniksi)

aspetjournals.org (Global: 6,663^rd place; Finnish: 2,918^th place)

jpet.aspetjournals.org

Simmler, L. D. ym.: In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1. The Journal of Pharmacology and Experimental Therapeutics, 2016, 357. vsk, nro 1, s. 134–144. PubMed:26791601 doi:10.1124/jpet.115.229765 ISSN 1521-0103 Artikkelin verkkoversio. (englanniksi)

benthamopen.com (Global: low place; Finnish: low place)

Karch, S. B.: A historical review of MDMA. The Open Forensic Science Journal, 2011, 4. vsk, nro 1, s. 20–24. doi:10.2174/1874402801104010020 Artikkelin verkkoversio. (englanniksi)

doi.org (Global: 2^nd place; Finnish: 10^th place)

dx.doi.org

Shulgin, A. T.: The background and chemistry of MDMA. Journal of Psychoactive Drugs, 1986, 18. vsk, nro 4, s. 291–304. PubMed:2880943 doi:10.1080/02791072.1986.10472361 ISSN 0279-1072 Artikkelin verkkoversio. (englanniksi)
Torre, R. ym.: MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant? Frontiers in Genetics, 2012, 3. vsk. PubMed:23162568 doi:10.3389/fgene.2012.00235 ISSN 1664-8021 Artikkelin verkkoversio. (englanniksi)
Meyer, J. S.: 3,4-methylenedioxymethamphetamine (MDMA): current perspectives. Substance Abuse and Rehabilitation, 2013, 4. vsk, s. 83–99. PubMed:24648791 doi:10.2147/SAR.S37258 ISSN 1179-8467 Artikkelin verkkoversio. (englanniksi)
Oeri, H. E.: Beyond ecstasy: alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy. Journal of Psychopharmacology, 2020. PubMed:32909493 doi:10.1177/0269881120920420 ISSN 0269-8811 Artikkelin verkkoversio. (englanniksi)
Recent changes in Europe’s MDMA / ecstasy market: results from an EMCDDA trendspotter study, April 2016. Publications Office, 2016. doi:10.2810/817237 ISBN 9789291689118 Teoksen verkkoversio. (englanniksi)
Vizeli, P. & Liechti, M. E.: Safety pharmacology of acute MDMA administration in healthy subjects. Journal of Psychopharmacology, 2017, 31. vsk, nro 5, s. 576–588. PubMed:28443695 doi:10.1177/0269881117691569 ISSN 1461-7285 Artikkelin verkkoversio. (englanniksi)
Liechti, M. E.: Effects of MDMA on body temperature in humans. Temperature: Multidisciplinary Biomedical Journal, 2014, 1. vsk, nro 3, s. 192–200. PubMed:27626046 doi:10.4161/23328940.2014.955433 ISSN 2332-8940 Artikkelin verkkoversio. (englanniksi)
Droogmans, S. ym.: Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease. The American Journal of Cardiology, 2007, 100. vsk, nro 9, s. 1442–1445. PubMed:17950805 doi:10.1016/j.amjcard.2007.06.045 ISSN 0002-9149 Artikkelin verkkoversio. (englanniksi)
Montastruc, F.: Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, ’Ecstasy’). British Journal of Clinical Pharmacology, 2012, 74. vsk, nro 3, s. 547–548. PubMed:22364182 doi:10.1111/j.1365-2125.2012.04252.x ISSN 0306-5251 Artikkelin verkkoversio. (englanniksi)
Karch, S. B.: A historical review of MDMA. The Open Forensic Science Journal, 2011, 4. vsk, nro 1, s. 20–24. doi:10.2174/1874402801104010020 Artikkelin verkkoversio. (englanniksi)
Freudenmann, R. W. & Oxler, F. & Bernschneider-Reif, S.: The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents. Addiction, 2006, 101. vsk, nro 9, s. 1241–1245. PubMed:16911722 doi:10.1111/j.1360-0443.2006.01511.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Passie, T. & Benzenhöfer, U.: MDA, MDMA, and other ”mescaline-like” substances in the US military’s search for a truth drug (1940s to 1960s). Drug Testing and Analysis, 2018, 10. vsk, nro 1, s. 72–80. PubMed:28851034 doi:10.1002/dta.2292 ISSN 1942-7611 Artikkelin verkkoversio. (englanniksi)
Benzenhöfer, U. & Passie, T.: Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin. Addiction, 2010, 105. vsk, nro 8, s. 1355–1361. PubMed:20653618 doi:10.1111/j.1360-0443.2010.02948.x ISSN 1360-0443 Artikkelin verkkoversio. (PDF) (englanniksi)
Passie, T. & Benzenhöfer, U.: The history of MDMA as an underground drug in the United States, 1960-1979. Journal of Psychoactive Drugs, 2016, 48. vsk, nro 2, s. 67–75. PubMed:26940772 doi:10.1080/02791072.2015.1128580 ISSN 0279-1072 Artikkelin verkkoversio. (englanniksi)
Sreenivasan, V. R.: Problems in identification of methylenediony and methoxy amphetamines. The Journal of Criminal Law, Criminology, and Police Science, 1972, 63. vsk, nro 2, s. 304–312. doi:10.2307/1142315 ISSN 0022-0205 JSTOR:1142315 Artikkelin verkkoversio. (englanniksi)
Passie, T.: The early use of MDMA (’Ecstasy’) in psychotherapy (1977–1985). Drug Science, Policy and Law, 2018, 4. vsk, nro 2. doi:10.1177/2050324518767442 ISSN 2050-3245 Artikkelin verkkoversio. (englanniksi)
Kemprai, P. ym.: Review on safrole: identity shift of the ’candy shop’ aroma to a carcinogen and deforester. Flavour and Fragrance Journal, 2020, 35. vsk, nro 1, s. 5–23. doi:10.1002/ffj.3521 ISSN 1099-1026 Artikkelin verkkoversio. (englanniksi)
Murnane, K. S. ym.: Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(−)-MDMA trained mice. The Journal of Pharmacology and Experimental Therapeutics, 2009, 331. vsk, nro 2, s. 717–723. PubMed:19684254 doi:10.1124/jpet.109.156174 ISSN 0022-3565 Artikkelin verkkoversio. (englanniksi)
Hauser, F. M. ym.: Identification of specific markers for amphetamines synthesized from glycidic acid pre‐precursors and retrospective search in German profiling database. Drug Testing and Analysis, 2020, 12. vsk, nro 1, s. 41–52. PubMed:31471943 doi:10.1002/dta.2686 ISSN 1942-7603 Artikkelin verkkoversio. (englanniksi)
Gimeno, P. ym.: A study of impurities in intermediates and 3,4-methylenedioxymethamphetamine (MDMA) samples produced via reductive amination routes. Forensic Science International, 2005, 155. vsk, nro 2-3, s. 141–157. PubMed:16226151 doi:10.1016/j.forsciint.2004.11.013 ISSN 0379-0738 Artikkelin verkkoversio. (englanniksi)
Levy, K. B. ym.: An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students. Substance use & misuse, 2005, 40. vsk, nro 9–10, s. 1427–1441. PubMed:16048826 doi:10.1081/JA-200066810 ISSN 1082-6084 Artikkelin verkkoversio. (englanniksi)
Brunt, T. M. ym.: Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology, 2012, 220. vsk, nro 4, s. 751–762. PubMed:21993879 doi:10.1007/s00213-011-2529-4 ISSN 1432-2072 Artikkelin verkkoversio. (englanniksi)
Allott, K. & Redman, J.: Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)? Neuroscience and Biobehavioral Reviews, 2007, 31. vsk, nro 3, s. 327–347. PubMed:17109962 doi:10.1016/j.neubiorev.2006.09.009 ISSN 0149-7634 Artikkelin verkkoversio. (englanniksi)
European Drug Report 2020, s. 10. EMCDDA, 2020. doi:10.2810/420678 ISBN 9789294975447 Teoksen verkkoversio (PDF). (englanniksi)
Baylen, C. A. & Rosenberg, H.: A review of the acute subjective effects of MDMA/ecstasy. Addiction, 2006, 101. vsk, nro 7, s. 933–947. PubMed:16771886 doi:10.1111/j.1360-0443.2006.01423.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Liechti, M. E. & Vollenweider, F. X.: Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Human Psychopharmacology: Clinical and Experimental, 2001, 16. vsk, nro 8, s. 589–598. doi:10.1002/hup.348 ISSN 1099-1077 Artikkelin verkkoversio. (englanniksi)
Mueller, F. ym.: Neuroimaging in moderate MDMA use: A systematic review. Neuroscience and Biobehavioral Reviews, 2016, nro 62, s. 21–34. PubMed:26746590 doi:10.1016/j.neubiorev.2015.12.010 ISSN 1873-7528 Artikkelin verkkoversio. (englanniksi)
Campbell, G. A. & Rosner, M. H.: The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Clinical Journal of the American Society of Nephrology, 2008, 3. vsk, nro 6, s. 1852–1860. PubMed:18684895 doi:10.2215/CJN.02080508 ISSN 1555-9041 Artikkelin verkkoversio. (englanniksi)
Armenian, P. ym.: Multiple MDMA (Ecstasy) overdoses at a rave event: a case series. Journal of Intensive Care Medicine, 2013, 28. vsk, nro 4, s. 252–258. PubMed:22640978 doi:10.1177/0885066612445982 ISSN 1525-1489 Artikkelin verkkoversio. (englanniksi)
RS Gable: Acute toxic effects of club drugs. Journal of Psychoactive Drugs, 2004, nro 3, s. 303–313. PubMed:15559678 doi:10.1080/02791072.2004.10400031 ISSN 0279-1072 Artikkelin verkkoversio. (englanniksi)
Gable, R. S.: Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction, 2004, 99. vsk, nro 6, s. 686–696. PubMed:15139867 doi:10.1111/j.1360-0443.2004.00744.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Silins, E. & Copeland, J. & Dillon, P.: Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk. The Australian and New Zealand Journal of Psychiatry, 2007, 41. vsk, nro 8, s. 649–655. PubMed:17620161 doi:10.1080/00048670701449237 ISSN 0004-8674 Artikkelin verkkoversio. (englanniksi)
Tancer, M. & Johanson, C.: The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology, 2007, 189. vsk, nro 4, s. 565–573. PubMed:17047932 doi:10.1007/s00213-006-0576-z ISSN 0033-3158 Artikkelin verkkoversio. (englanniksi)
Aguilar, M. A. & García-Pardo, M. P. & Parrott, A. C.: Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (’Ecstasy’). Brain Research, 2020, 78. vsk, s. 209-241. PubMed:31812710 doi:10.1016/j.brainres.2019.146556 ISSN 0006-8993 Artikkelin verkkoversio. (englanniksi)
Singer, L. T. ym.: Motor delays in MDMA (Ecstasy) exposed infants persist to 2 Years. Neurotoxicology and teratology, 2016, nro 54, s. 22. PubMed:26806601 doi:10.1016/j.ntt.2016.01.003 Artikkelin verkkoversio. (englanniksi)
Farré, M.: Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology, 2004, 173. vsk, nro 3-4, s. 364–375. PubMed:15071716 doi:10.1007/s00213-004-1789-7 ISSN 0033-3158 Artikkelin verkkoversio. (englanniksi)
Parrott, A. C.: Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. Journal of Psychopharmacology, 2005, 19. vsk, nro 1, s. 71–83. PubMed:15671132 doi:10.1177/0269881105048900 ISSN 0269-8811 Artikkelin verkkoversio. (englanniksi)
Cottler, L. B. & Leung, K. S. & Abdallah, A. B.: Test retest reliability of DSM-IV adopted criteria for MDMA abuse and dependence: A cross-national study. Addiction, 2009, 104. vsk, nro 10, s. 1679–1690. PubMed:19681802 doi:10.1111/j.1360-0443.2009.02649.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Sitte, H. H. & Freissmuth, M.: Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends in pharmacological sciences, 2015, 36. vsk, nro 1, s. 41–50. PubMed:25542076 doi:10.1016/j.tips.2014.11.006 ISSN 0165-6147 Artikkelin verkkoversio. (englanniksi)
Reyes-Parada, M. & Iturriaga-Vasquez, P. & Cassels, B. K.: Amphetamine derivatives as monoamine oxidase inhibitors. Frontiers in Pharmacology, 2020, 10. vsk. PubMed:32038257 doi:10.3389/fphar.2019.01590 ISSN 1663-9812 Artikkelin verkkoversio. (englanniksi)
Pitts, E. G. ym.: (±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA. Psychopharmacology, 2018, nro 2, s. 377–392. PubMed:29248945 doi:10.1007/s00213-017-4812-5 ISSN 1432-2072 Artikkelin verkkoversio. (englanniksi)
Simmler, L. D. ym.: In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1. The Journal of Pharmacology and Experimental Therapeutics, 2016, 357. vsk, nro 1, s. 134–144. PubMed:26791601 doi:10.1124/jpet.115.229765 ISSN 1521-0103 Artikkelin verkkoversio. (englanniksi)
Luethi, D. ym.: Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems. Journal of Psychopharmacology, 2019. PubMed:31038382 doi:10.1177/0269881119844185 Artikkelin verkkoversio. (englanniksi)
Steuer, A. E. ym.: Impact of cytochrome P450 2D6 function on the chiral blood plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its phase I and II metabolites in humans. PLOS ONE, 2016, 11. vsk, nro 3, s. e0150955. doi:10.1371/journal.pone.0150955 ISSN 1932-6203 Artikkelin verkkoversio. (englanniksi)
Schwaninger, A. E. ym.: Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. Clinical chemistry, 2011, 57. vsk, nro 12, s. 1748–1756. PubMed:21980168 doi:10.1373/clinchem.2011.172254 ISSN 0009-9147 Artikkelin verkkoversio. (englanniksi)
Papaseit, E. ym.: Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV). Intensive Care Medicine, 2012, 38. vsk, nro 7, s. 1239–1240. doi:10.1007/s00134-012-2537-9 ISSN 1432-1238 Artikkelin verkkoversio. (englanniksi)

erowid.org (Global: 3,887^th place; Finnish: 839^th place)

Stillman, RC ym.: ”Characterization of three new psychotomimetics. The Pharmacology of Hallucinogens”, The psychopharmacology of hallucinogens, s. 74–83. Pergamon Press, 1978. ISBN 9780080219387 Teoksen verkkoversio. (englanniksi)

europa.eu (Global: 68^th place; Finnish: 51^st place)

emcdda.europa.eu

Recent changes in Europe’s MDMA / ecstasy market: results from an EMCDDA trendspotter study, April 2016. Publications Office, 2016. doi:10.2810/817237 ISBN 9789291689118 Teoksen verkkoversio. (englanniksi)
European Drug Report 2020, s. 10. EMCDDA, 2020. doi:10.2810/420678 ISBN 9789294975447 Teoksen verkkoversio (PDF). (englanniksi)

europepmc.org (Global: 8,929^th place; Finnish: low place)

Freudenmann, R. W. & Oxler, F. & Bernschneider-Reif, S.: The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents. Addiction, 2006, 101. vsk, nro 9, s. 1241–1245. PubMed:16911722 doi:10.1111/j.1360-0443.2006.01511.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)

findlaw.com (Global: 1,478^th place; Finnish: 6,146^th place)

caselaw.findlaw.com

UNITED STATES v. CARLSON caselaw.findlaw.com. Arkistoitu 7.3.2017. Viitattu 29.11.2020. (englanniksi)

finlex.fi (Global: 3,070^th place; Finnish: 17^th place)

KKO:2005:56 finlex.fi. Viitattu 27.11.2020.

globaldrugsurvey.com (Global: low place; Finnish: low place)

GDS 2020: MDMA: not just about the dose but how you divide it (or not) Global Drug Survey. Viitattu 27.11.2020. (englanniksi)

jstor.org (Global: 26^th place; Finnish: 312^th place)

Sreenivasan, V. R.: Problems in identification of methylenediony and methoxy amphetamines. The Journal of Criminal Law, Criminology, and Police Science, 1972, 63. vsk, nro 2, s. 304–312. doi:10.2307/1142315 ISSN 0022-0205 JSTOR:1142315 Artikkelin verkkoversio. (englanniksi)

maps.org (Global: low place; Finnish: 5,059^th place)

maps.org

MDMA-Assisted Psychotherapy - MAPS maps.org. Viitattu 27.11.2020. (englanniksi)
Simek, Peter: Playboy: ecstasy was legal in 1984, and it was glorious maps.org. 2.12.2015. Arkistoitu 6.11.2020. Viitattu 29.11.2020. (englanniksi)
FDA Grants Breakthrough Therapy Designation for MDMA-Assisted Psychotherapy for PTSD, Agrees on Special Protocol Assessment for Phase 3 Trials maps.org. 26.8.2017. Viitattu 27.11.2020. (englanniksi)
MDMA Research News Timeline maps.org. 21.12.2020. Arkistoitu 21.7.2019. Viitattu 2.1.2021. (englanniksi)

bibliography.maps.org

Passie, T. & Benzenhöfer, U.: MDA, MDMA, and other ”mescaline-like” substances in the US military’s search for a truth drug (1940s to 1960s). Drug Testing and Analysis, 2018, 10. vsk, nro 1, s. 72–80. PubMed:28851034 doi:10.1002/dta.2292 ISSN 1942-7611 Artikkelin verkkoversio. (englanniksi)

mapscontent.s3-us-west-1.amazonaws.com (Global: low place; Finnish: low place)

MDMA Investigator’s Brochure, s. 68. Multidisciplinary Association for Psychedelic Studies, 2020. Teoksen verkkoversio. (englanniksi)

mapseurope.eu (Global: low place; Finnish: low place)

MAPS Europe MDMA-Assisted Psychotherapy for Europe. Viitattu 27.11.2020. (englanniksi)

nih.gov (Global: 4^th place; Finnish: 12^th place)

pubmed.ncbi.nlm.nih.gov

Shulgin, A. T.: The background and chemistry of MDMA. Journal of Psychoactive Drugs, 1986, 18. vsk, nro 4, s. 291–304. PubMed:2880943 doi:10.1080/02791072.1986.10472361 ISSN 0279-1072 Artikkelin verkkoversio. (englanniksi)
Torre, R. ym.: MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant? Frontiers in Genetics, 2012, 3. vsk. PubMed:23162568 doi:10.3389/fgene.2012.00235 ISSN 1664-8021 Artikkelin verkkoversio. (englanniksi)
Meyer, J. S.: 3,4-methylenedioxymethamphetamine (MDMA): current perspectives. Substance Abuse and Rehabilitation, 2013, 4. vsk, s. 83–99. PubMed:24648791 doi:10.2147/SAR.S37258 ISSN 1179-8467 Artikkelin verkkoversio. (englanniksi)
Oeri, H. E.: Beyond ecstasy: alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy. Journal of Psychopharmacology, 2020. PubMed:32909493 doi:10.1177/0269881120920420 ISSN 0269-8811 Artikkelin verkkoversio. (englanniksi)
Vizeli, P. & Liechti, M. E.: Safety pharmacology of acute MDMA administration in healthy subjects. Journal of Psychopharmacology, 2017, 31. vsk, nro 5, s. 576–588. PubMed:28443695 doi:10.1177/0269881117691569 ISSN 1461-7285 Artikkelin verkkoversio. (englanniksi)
Liechti, M. E.: Effects of MDMA on body temperature in humans. Temperature: Multidisciplinary Biomedical Journal, 2014, 1. vsk, nro 3, s. 192–200. PubMed:27626046 doi:10.4161/23328940.2014.955433 ISSN 2332-8940 Artikkelin verkkoversio. (englanniksi)
Droogmans, S. ym.: Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease. The American Journal of Cardiology, 2007, 100. vsk, nro 9, s. 1442–1445. PubMed:17950805 doi:10.1016/j.amjcard.2007.06.045 ISSN 0002-9149 Artikkelin verkkoversio. (englanniksi)
Montastruc, F.: Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, ’Ecstasy’). British Journal of Clinical Pharmacology, 2012, 74. vsk, nro 3, s. 547–548. PubMed:22364182 doi:10.1111/j.1365-2125.2012.04252.x ISSN 0306-5251 Artikkelin verkkoversio. (englanniksi)
Freudenmann, R. W. & Oxler, F. & Bernschneider-Reif, S.: The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents. Addiction, 2006, 101. vsk, nro 9, s. 1241–1245. PubMed:16911722 doi:10.1111/j.1360-0443.2006.01511.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Passie, T. & Benzenhöfer, U.: MDA, MDMA, and other ”mescaline-like” substances in the US military’s search for a truth drug (1940s to 1960s). Drug Testing and Analysis, 2018, 10. vsk, nro 1, s. 72–80. PubMed:28851034 doi:10.1002/dta.2292 ISSN 1942-7611 Artikkelin verkkoversio. (englanniksi)
Benzenhöfer, U. & Passie, T.: Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin. Addiction, 2010, 105. vsk, nro 8, s. 1355–1361. PubMed:20653618 doi:10.1111/j.1360-0443.2010.02948.x ISSN 1360-0443 Artikkelin verkkoversio. (PDF) (englanniksi)
Passie, T. & Benzenhöfer, U.: The history of MDMA as an underground drug in the United States, 1960-1979. Journal of Psychoactive Drugs, 2016, 48. vsk, nro 2, s. 67–75. PubMed:26940772 doi:10.1080/02791072.2015.1128580 ISSN 0279-1072 Artikkelin verkkoversio. (englanniksi)
Anderson, G. M. ym.: Absolute configuration and psychotomimetic activity. NIDA research monograph, 1978, 22. vsk, s. 8–15. PubMed:101890 ISSN 1046-9516 Artikkelin verkkoversio. (englanniksi)
Murnane, K. S. ym.: Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(−)-MDMA trained mice. The Journal of Pharmacology and Experimental Therapeutics, 2009, 331. vsk, nro 2, s. 717–723. PubMed:19684254 doi:10.1124/jpet.109.156174 ISSN 0022-3565 Artikkelin verkkoversio. (englanniksi)
Hauser, F. M. ym.: Identification of specific markers for amphetamines synthesized from glycidic acid pre‐precursors and retrospective search in German profiling database. Drug Testing and Analysis, 2020, 12. vsk, nro 1, s. 41–52. PubMed:31471943 doi:10.1002/dta.2686 ISSN 1942-7603 Artikkelin verkkoversio. (englanniksi)
Gimeno, P. ym.: A study of impurities in intermediates and 3,4-methylenedioxymethamphetamine (MDMA) samples produced via reductive amination routes. Forensic Science International, 2005, 155. vsk, nro 2-3, s. 141–157. PubMed:16226151 doi:10.1016/j.forsciint.2004.11.013 ISSN 0379-0738 Artikkelin verkkoversio. (englanniksi)
Levy, K. B. ym.: An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students. Substance use & misuse, 2005, 40. vsk, nro 9–10, s. 1427–1441. PubMed:16048826 doi:10.1081/JA-200066810 ISSN 1082-6084 Artikkelin verkkoversio. (englanniksi)
Brunt, T. M. ym.: Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology, 2012, 220. vsk, nro 4, s. 751–762. PubMed:21993879 doi:10.1007/s00213-011-2529-4 ISSN 1432-2072 Artikkelin verkkoversio. (englanniksi)
Allott, K. & Redman, J.: Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)? Neuroscience and Biobehavioral Reviews, 2007, 31. vsk, nro 3, s. 327–347. PubMed:17109962 doi:10.1016/j.neubiorev.2006.09.009 ISSN 0149-7634 Artikkelin verkkoversio. (englanniksi)
Baylen, C. A. & Rosenberg, H.: A review of the acute subjective effects of MDMA/ecstasy. Addiction, 2006, 101. vsk, nro 7, s. 933–947. PubMed:16771886 doi:10.1111/j.1360-0443.2006.01423.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Mueller, F. ym.: Neuroimaging in moderate MDMA use: A systematic review. Neuroscience and Biobehavioral Reviews, 2016, nro 62, s. 21–34. PubMed:26746590 doi:10.1016/j.neubiorev.2015.12.010 ISSN 1873-7528 Artikkelin verkkoversio. (englanniksi)
Campbell, G. A. & Rosner, M. H.: The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Clinical Journal of the American Society of Nephrology, 2008, 3. vsk, nro 6, s. 1852–1860. PubMed:18684895 doi:10.2215/CJN.02080508 ISSN 1555-9041 Artikkelin verkkoversio. (englanniksi)
Armenian, P. ym.: Multiple MDMA (Ecstasy) overdoses at a rave event: a case series. Journal of Intensive Care Medicine, 2013, 28. vsk, nro 4, s. 252–258. PubMed:22640978 doi:10.1177/0885066612445982 ISSN 1525-1489 Artikkelin verkkoversio. (englanniksi)
RS Gable: Acute toxic effects of club drugs. Journal of Psychoactive Drugs, 2004, nro 3, s. 303–313. PubMed:15559678 doi:10.1080/02791072.2004.10400031 ISSN 0279-1072 Artikkelin verkkoversio. (englanniksi)
Gable, R. S.: Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction, 2004, 99. vsk, nro 6, s. 686–696. PubMed:15139867 doi:10.1111/j.1360-0443.2004.00744.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Silins, E. & Copeland, J. & Dillon, P.: Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk. The Australian and New Zealand Journal of Psychiatry, 2007, 41. vsk, nro 8, s. 649–655. PubMed:17620161 doi:10.1080/00048670701449237 ISSN 0004-8674 Artikkelin verkkoversio. (englanniksi)
Tancer, M. & Johanson, C.: The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology, 2007, 189. vsk, nro 4, s. 565–573. PubMed:17047932 doi:10.1007/s00213-006-0576-z ISSN 0033-3158 Artikkelin verkkoversio. (englanniksi)
Aguilar, M. A. & García-Pardo, M. P. & Parrott, A. C.: Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (’Ecstasy’). Brain Research, 2020, 78. vsk, s. 209-241. PubMed:31812710 doi:10.1016/j.brainres.2019.146556 ISSN 0006-8993 Artikkelin verkkoversio. (englanniksi)
Singer, L. T. ym.: Motor delays in MDMA (Ecstasy) exposed infants persist to 2 Years. Neurotoxicology and teratology, 2016, nro 54, s. 22. PubMed:26806601 doi:10.1016/j.ntt.2016.01.003 Artikkelin verkkoversio. (englanniksi)
Farré, M.: Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology, 2004, 173. vsk, nro 3-4, s. 364–375. PubMed:15071716 doi:10.1007/s00213-004-1789-7 ISSN 0033-3158 Artikkelin verkkoversio. (englanniksi)
Parrott, A. C.: Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. Journal of Psychopharmacology, 2005, 19. vsk, nro 1, s. 71–83. PubMed:15671132 doi:10.1177/0269881105048900 ISSN 0269-8811 Artikkelin verkkoversio. (englanniksi)
Cottler, L. B. & Leung, K. S. & Abdallah, A. B.: Test retest reliability of DSM-IV adopted criteria for MDMA abuse and dependence: A cross-national study. Addiction, 2009, 104. vsk, nro 10, s. 1679–1690. PubMed:19681802 doi:10.1111/j.1360-0443.2009.02649.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Sitte, H. H. & Freissmuth, M.: Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends in pharmacological sciences, 2015, 36. vsk, nro 1, s. 41–50. PubMed:25542076 doi:10.1016/j.tips.2014.11.006 ISSN 0165-6147 Artikkelin verkkoversio. (englanniksi)
Reyes-Parada, M. & Iturriaga-Vasquez, P. & Cassels, B. K.: Amphetamine derivatives as monoamine oxidase inhibitors. Frontiers in Pharmacology, 2020, 10. vsk. PubMed:32038257 doi:10.3389/fphar.2019.01590 ISSN 1663-9812 Artikkelin verkkoversio. (englanniksi)
Pitts, E. G. ym.: (±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA. Psychopharmacology, 2018, nro 2, s. 377–392. PubMed:29248945 doi:10.1007/s00213-017-4812-5 ISSN 1432-2072 Artikkelin verkkoversio. (englanniksi)
Simmler, L. D. ym.: In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1. The Journal of Pharmacology and Experimental Therapeutics, 2016, 357. vsk, nro 1, s. 134–144. PubMed:26791601 doi:10.1124/jpet.115.229765 ISSN 1521-0103 Artikkelin verkkoversio. (englanniksi)
Luethi, D. ym.: Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems. Journal of Psychopharmacology, 2019. PubMed:31038382 doi:10.1177/0269881119844185 Artikkelin verkkoversio. (englanniksi)
Schwaninger, A. E. ym.: Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. Clinical chemistry, 2011, 57. vsk, nro 12, s. 1748–1756. PubMed:21980168 doi:10.1373/clinchem.2011.172254 ISSN 0009-9147 Artikkelin verkkoversio. (englanniksi)

ncbi.nlm.nih.gov

Torre, R. ym.: MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant? Frontiers in Genetics, 2012, 3. vsk. PubMed:23162568 doi:10.3389/fgene.2012.00235 ISSN 1664-8021 Artikkelin verkkoversio. (englanniksi)
Meyer, J. S.: 3,4-methylenedioxymethamphetamine (MDMA): current perspectives. Substance Abuse and Rehabilitation, 2013, 4. vsk, s. 83–99. PubMed:24648791 doi:10.2147/SAR.S37258 ISSN 1179-8467 Artikkelin verkkoversio. (englanniksi)
Liechti, M. E.: Effects of MDMA on body temperature in humans. Temperature: Multidisciplinary Biomedical Journal, 2014, 1. vsk, nro 3, s. 192–200. PubMed:27626046 doi:10.4161/23328940.2014.955433 ISSN 2332-8940 Artikkelin verkkoversio. (englanniksi)
Montastruc, F.: Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, ’Ecstasy’). British Journal of Clinical Pharmacology, 2012, 74. vsk, nro 3, s. 547–548. PubMed:22364182 doi:10.1111/j.1365-2125.2012.04252.x ISSN 0306-5251 Artikkelin verkkoversio. (englanniksi)
Murnane, K. S. ym.: Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(−)-MDMA trained mice. The Journal of Pharmacology and Experimental Therapeutics, 2009, 331. vsk, nro 2, s. 717–723. PubMed:19684254 doi:10.1124/jpet.109.156174 ISSN 0022-3565 Artikkelin verkkoversio. (englanniksi)
Levy, K. B. ym.: An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students. Substance use & misuse, 2005, 40. vsk, nro 9–10, s. 1427–1441. PubMed:16048826 doi:10.1081/JA-200066810 ISSN 1082-6084 Artikkelin verkkoversio. (englanniksi)
Singer, L. T. ym.: Motor delays in MDMA (Ecstasy) exposed infants persist to 2 Years. Neurotoxicology and teratology, 2016, nro 54, s. 22. PubMed:26806601 doi:10.1016/j.ntt.2016.01.003 Artikkelin verkkoversio. (englanniksi)
Cottler, L. B. & Leung, K. S. & Abdallah, A. B.: Test retest reliability of DSM-IV adopted criteria for MDMA abuse and dependence: A cross-national study. Addiction, 2009, 104. vsk, nro 10, s. 1679–1690. PubMed:19681802 doi:10.1111/j.1360-0443.2009.02649.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Sitte, H. H. & Freissmuth, M.: Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends in pharmacological sciences, 2015, 36. vsk, nro 1, s. 41–50. PubMed:25542076 doi:10.1016/j.tips.2014.11.006 ISSN 0165-6147 Artikkelin verkkoversio. (englanniksi)
Reyes-Parada, M. & Iturriaga-Vasquez, P. & Cassels, B. K.: Amphetamine derivatives as monoamine oxidase inhibitors. Frontiers in Pharmacology, 2020, 10. vsk. PubMed:32038257 doi:10.3389/fphar.2019.01590 ISSN 1663-9812 Artikkelin verkkoversio. (englanniksi)
Steuer, A. E. ym.: Impact of cytochrome P450 2D6 function on the chiral blood plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its phase I and II metabolites in humans. PLOS ONE, 2016, 11. vsk, nro 3, s. e0150955. doi:10.1371/journal.pone.0150955 ISSN 1932-6203 Artikkelin verkkoversio. (englanniksi)
Schwaninger, A. E. ym.: Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. Clinical chemistry, 2011, 57. vsk, nro 12, s. 1748–1756. PubMed:21980168 doi:10.1373/clinchem.2011.172254 ISSN 0009-9147 Artikkelin verkkoversio. (englanniksi)

northwestern.edu (Global: 2,302^nd place; Finnish: 9,196^th place)

scholarlycommons.law.northwestern.edu

Sreenivasan, V. R.: Problems in identification of methylenediony and methoxy amphetamines. The Journal of Criminal Law, Criminology, and Police Science, 1972, 63. vsk, nro 2, s. 304–312. doi:10.2307/1142315 ISSN 0022-0205 JSTOR:1142315 Artikkelin verkkoversio. (englanniksi)

psu.edu (Global: 207^th place; Finnish: 1,082^nd place)

citeseerx.ist.psu.edu

Benzenhöfer, U. & Passie, T.: Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin. Addiction, 2010, 105. vsk, nro 8, s. 1355–1361. PubMed:20653618 doi:10.1111/j.1360-0443.2010.02948.x ISSN 1360-0443 Artikkelin verkkoversio. (PDF) (englanniksi)

researchgate.net (Global: 120^th place; Finnish: 243^rd place)

Anderson, G. M. ym.: Absolute configuration and psychotomimetic activity. NIDA research monograph, 1978, 22. vsk, s. 8–15. PubMed:101890 ISSN 1046-9516 Artikkelin verkkoversio. (englanniksi)
Brunt, T. M. ym.: Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology, 2012, 220. vsk, nro 4, s. 751–762. PubMed:21993879 doi:10.1007/s00213-011-2529-4 ISSN 1432-2072 Artikkelin verkkoversio. (englanniksi)
Allott, K. & Redman, J.: Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)? Neuroscience and Biobehavioral Reviews, 2007, 31. vsk, nro 3, s. 327–347. PubMed:17109962 doi:10.1016/j.neubiorev.2006.09.009 ISSN 0149-7634 Artikkelin verkkoversio. (englanniksi)
RS Gable: Acute toxic effects of club drugs. Journal of Psychoactive Drugs, 2004, nro 3, s. 303–313. PubMed:15559678 doi:10.1080/02791072.2004.10400031 ISSN 0279-1072 Artikkelin verkkoversio. (englanniksi)
Gable, R. S.: Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction, 2004, 99. vsk, nro 6, s. 686–696. PubMed:15139867 doi:10.1111/j.1360-0443.2004.00744.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Silins, E. & Copeland, J. & Dillon, P.: Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk. The Australian and New Zealand Journal of Psychiatry, 2007, 41. vsk, nro 8, s. 649–655. PubMed:17620161 doi:10.1080/00048670701449237 ISSN 0004-8674 Artikkelin verkkoversio. (englanniksi)
Farré, M.: Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology, 2004, 173. vsk, nro 3-4, s. 364–375. PubMed:15071716 doi:10.1007/s00213-004-1789-7 ISSN 0033-3158 Artikkelin verkkoversio. (englanniksi)
Parrott, A. C.: Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. Journal of Psychopharmacology, 2005, 19. vsk, nro 1, s. 71–83. PubMed:15671132 doi:10.1177/0269881105048900 ISSN 0269-8811 Artikkelin verkkoversio. (englanniksi)

rollsafe.org (Global: low place; Finnish: low place)

MDMA (Molly/Ecstasy) Test Kits rollsafe.org. 4.5.2017. Viitattu 28.11.2020. (englanniksi)

sagepub.com (Global: 731^st place; Finnish: 767^th place)

journals.sagepub.com

Oeri, H. E.: Beyond ecstasy: alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy. Journal of Psychopharmacology, 2020. PubMed:32909493 doi:10.1177/0269881120920420 ISSN 0269-8811 Artikkelin verkkoversio. (englanniksi)
Vizeli, P. & Liechti, M. E.: Safety pharmacology of acute MDMA administration in healthy subjects. Journal of Psychopharmacology, 2017, 31. vsk, nro 5, s. 576–588. PubMed:28443695 doi:10.1177/0269881117691569 ISSN 1461-7285 Artikkelin verkkoversio. (englanniksi)
Passie, T.: The early use of MDMA (’Ecstasy’) in psychotherapy (1977–1985). Drug Science, Policy and Law, 2018, 4. vsk, nro 2. doi:10.1177/2050324518767442 ISSN 2050-3245 Artikkelin verkkoversio. (englanniksi)
Armenian, P. ym.: Multiple MDMA (Ecstasy) overdoses at a rave event: a case series. Journal of Intensive Care Medicine, 2013, 28. vsk, nro 4, s. 252–258. PubMed:22640978 doi:10.1177/0885066612445982 ISSN 1525-1489 Artikkelin verkkoversio. (englanniksi)
Luethi, D. ym.: Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems. Journal of Psychopharmacology, 2019. PubMed:31038382 doi:10.1177/0269881119844185 Artikkelin verkkoversio. (englanniksi)

sciencedirect.com (Global: 149^th place; Finnish: 237^th place)

Gimeno, P. ym.: A study of impurities in intermediates and 3,4-methylenedioxymethamphetamine (MDMA) samples produced via reductive amination routes. Forensic Science International, 2005, 155. vsk, nro 2-3, s. 141–157. PubMed:16226151 doi:10.1016/j.forsciint.2004.11.013 ISSN 0379-0738 Artikkelin verkkoversio. (englanniksi)
Aguilar, M. A. & García-Pardo, M. P. & Parrott, A. C.: Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (’Ecstasy’). Brain Research, 2020, 78. vsk, s. 209-241. PubMed:31812710 doi:10.1016/j.brainres.2019.146556 ISSN 0006-8993 Artikkelin verkkoversio. (englanniksi)

springer.com (Global: 274^th place; Finnish: 418^th place)

link.springer.com

Tancer, M. & Johanson, C.: The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology, 2007, 189. vsk, nro 4, s. 565–573. PubMed:17047932 doi:10.1007/s00213-006-0576-z ISSN 0033-3158 Artikkelin verkkoversio. (englanniksi)
Pitts, E. G. ym.: (±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA. Psychopharmacology, 2018, nro 2, s. 377–392. PubMed:29248945 doi:10.1007/s00213-017-4812-5 ISSN 1432-2072 Artikkelin verkkoversio. (englanniksi)
Papaseit, E. ym.: Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV). Intensive Care Medicine, 2012, 38. vsk, nro 7, s. 1239–1240. doi:10.1007/s00134-012-2537-9 ISSN 1432-1238 Artikkelin verkkoversio. (englanniksi)

tandfonline.com (Global: 507^th place; Finnish: 559^th place)

Shulgin, A. T.: The background and chemistry of MDMA. Journal of Psychoactive Drugs, 1986, 18. vsk, nro 4, s. 291–304. PubMed:2880943 doi:10.1080/02791072.1986.10472361 ISSN 0279-1072 Artikkelin verkkoversio. (englanniksi)
Passie, T. & Benzenhöfer, U.: The history of MDMA as an underground drug in the United States, 1960-1979. Journal of Psychoactive Drugs, 2016, 48. vsk, nro 2, s. 67–75. PubMed:26940772 doi:10.1080/02791072.2015.1128580 ISSN 0279-1072 Artikkelin verkkoversio. (englanniksi)

tietopyynto.fi (Global: low place; Finnish: 5,926^th place)

Värireagenssin tilaaminen Suomeen tietopyynto.fi. 10.5.2018. Viitattu 28.11.2020.

unibas.ch (Global: low place; Finnish: low place)

edoc.unibas.ch

Mueller, F. ym.: Neuroimaging in moderate MDMA use: A systematic review. Neuroscience and Biobehavioral Reviews, 2016, nro 62, s. 21–34. PubMed:26746590 doi:10.1016/j.neubiorev.2015.12.010 ISSN 1873-7528 Artikkelin verkkoversio. (englanniksi)

urn.fi (Global: 8,035^th place; Finnish: 70^th place)

Karjalainen, K & Pekkanen, N. & Hakkarainen, P.: Suomalaisten huumeiden käyttö ja huumeasenteet: Huumeaiheiset väestökyselyt Suomessa 1992-2018, s. 59–60. THL, 2020. ISBN 9789523434417 Teoksen verkkoversio.

web.archive.org (Global: 1^st place; Finnish: 1^st place)

Simek, Peter: Playboy: ecstasy was legal in 1984, and it was glorious maps.org. 2.12.2015. Arkistoitu 6.11.2020. Viitattu 29.11.2020. (englanniksi)
Baker, Kathryn: DEA to ban ”ecstasy” – the drug MDMA apnews.com. 31.5.1986. Arkistoitu 29.11.2020. Viitattu 29.11.2020. (englanniksi)
UNITED STATES v. CARLSON caselaw.findlaw.com. Arkistoitu 7.3.2017. Viitattu 29.11.2020. (englanniksi)
MDMA Research News Timeline maps.org. 21.12.2020. Arkistoitu 21.7.2019. Viitattu 2.1.2021. (englanniksi)

wiley.com (Global: 222^nd place; Finnish: 202^nd place)

onlinelibrary.wiley.com

Kemprai, P. ym.: Review on safrole: identity shift of the ’candy shop’ aroma to a carcinogen and deforester. Flavour and Fragrance Journal, 2020, 35. vsk, nro 1, s. 5–23. doi:10.1002/ffj.3521 ISSN 1099-1026 Artikkelin verkkoversio. (englanniksi)
Hauser, F. M. ym.: Identification of specific markers for amphetamines synthesized from glycidic acid pre‐precursors and retrospective search in German profiling database. Drug Testing and Analysis, 2020, 12. vsk, nro 1, s. 41–52. PubMed:31471943 doi:10.1002/dta.2686 ISSN 1942-7603 Artikkelin verkkoversio. (englanniksi)
Baylen, C. A. & Rosenberg, H.: A review of the acute subjective effects of MDMA/ecstasy. Addiction, 2006, 101. vsk, nro 7, s. 933–947. PubMed:16771886 doi:10.1111/j.1360-0443.2006.01423.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Liechti, M. E. & Vollenweider, F. X.: Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Human Psychopharmacology: Clinical and Experimental, 2001, 16. vsk, nro 8, s. 589–598. doi:10.1002/hup.348 ISSN 1099-1077 Artikkelin verkkoversio. (englanniksi)

worldcat.org (Global: 5^th place; Finnish: 9^th place)

Shulgin, A. T.: The background and chemistry of MDMA. Journal of Psychoactive Drugs, 1986, 18. vsk, nro 4, s. 291–304. PubMed:2880943 doi:10.1080/02791072.1986.10472361 ISSN 0279-1072 Artikkelin verkkoversio. (englanniksi)
Torre, R. ym.: MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant? Frontiers in Genetics, 2012, 3. vsk. PubMed:23162568 doi:10.3389/fgene.2012.00235 ISSN 1664-8021 Artikkelin verkkoversio. (englanniksi)
Meyer, J. S.: 3,4-methylenedioxymethamphetamine (MDMA): current perspectives. Substance Abuse and Rehabilitation, 2013, 4. vsk, s. 83–99. PubMed:24648791 doi:10.2147/SAR.S37258 ISSN 1179-8467 Artikkelin verkkoversio. (englanniksi)
Oeri, H. E.: Beyond ecstasy: alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy. Journal of Psychopharmacology, 2020. PubMed:32909493 doi:10.1177/0269881120920420 ISSN 0269-8811 Artikkelin verkkoversio. (englanniksi)
Vizeli, P. & Liechti, M. E.: Safety pharmacology of acute MDMA administration in healthy subjects. Journal of Psychopharmacology, 2017, 31. vsk, nro 5, s. 576–588. PubMed:28443695 doi:10.1177/0269881117691569 ISSN 1461-7285 Artikkelin verkkoversio. (englanniksi)
Liechti, M. E.: Effects of MDMA on body temperature in humans. Temperature: Multidisciplinary Biomedical Journal, 2014, 1. vsk, nro 3, s. 192–200. PubMed:27626046 doi:10.4161/23328940.2014.955433 ISSN 2332-8940 Artikkelin verkkoversio. (englanniksi)
Droogmans, S. ym.: Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease. The American Journal of Cardiology, 2007, 100. vsk, nro 9, s. 1442–1445. PubMed:17950805 doi:10.1016/j.amjcard.2007.06.045 ISSN 0002-9149 Artikkelin verkkoversio. (englanniksi)
Montastruc, F.: Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, ’Ecstasy’). British Journal of Clinical Pharmacology, 2012, 74. vsk, nro 3, s. 547–548. PubMed:22364182 doi:10.1111/j.1365-2125.2012.04252.x ISSN 0306-5251 Artikkelin verkkoversio. (englanniksi)
Freudenmann, R. W. & Oxler, F. & Bernschneider-Reif, S.: The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents. Addiction, 2006, 101. vsk, nro 9, s. 1241–1245. PubMed:16911722 doi:10.1111/j.1360-0443.2006.01511.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Passie, T. & Benzenhöfer, U.: MDA, MDMA, and other ”mescaline-like” substances in the US military’s search for a truth drug (1940s to 1960s). Drug Testing and Analysis, 2018, 10. vsk, nro 1, s. 72–80. PubMed:28851034 doi:10.1002/dta.2292 ISSN 1942-7611 Artikkelin verkkoversio. (englanniksi)
Benzenhöfer, U. & Passie, T.: Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin. Addiction, 2010, 105. vsk, nro 8, s. 1355–1361. PubMed:20653618 doi:10.1111/j.1360-0443.2010.02948.x ISSN 1360-0443 Artikkelin verkkoversio. (PDF) (englanniksi)
Passie, T. & Benzenhöfer, U.: The history of MDMA as an underground drug in the United States, 1960-1979. Journal of Psychoactive Drugs, 2016, 48. vsk, nro 2, s. 67–75. PubMed:26940772 doi:10.1080/02791072.2015.1128580 ISSN 0279-1072 Artikkelin verkkoversio. (englanniksi)
Sreenivasan, V. R.: Problems in identification of methylenediony and methoxy amphetamines. The Journal of Criminal Law, Criminology, and Police Science, 1972, 63. vsk, nro 2, s. 304–312. doi:10.2307/1142315 ISSN 0022-0205 JSTOR:1142315 Artikkelin verkkoversio. (englanniksi)
Anderson, G. M. ym.: Absolute configuration and psychotomimetic activity. NIDA research monograph, 1978, 22. vsk, s. 8–15. PubMed:101890 ISSN 1046-9516 Artikkelin verkkoversio. (englanniksi)
Passie, T.: The early use of MDMA (’Ecstasy’) in psychotherapy (1977–1985). Drug Science, Policy and Law, 2018, 4. vsk, nro 2. doi:10.1177/2050324518767442 ISSN 2050-3245 Artikkelin verkkoversio. (englanniksi)
Kemprai, P. ym.: Review on safrole: identity shift of the ’candy shop’ aroma to a carcinogen and deforester. Flavour and Fragrance Journal, 2020, 35. vsk, nro 1, s. 5–23. doi:10.1002/ffj.3521 ISSN 1099-1026 Artikkelin verkkoversio. (englanniksi)
Murnane, K. S. ym.: Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(−)-MDMA trained mice. The Journal of Pharmacology and Experimental Therapeutics, 2009, 331. vsk, nro 2, s. 717–723. PubMed:19684254 doi:10.1124/jpet.109.156174 ISSN 0022-3565 Artikkelin verkkoversio. (englanniksi)
Hauser, F. M. ym.: Identification of specific markers for amphetamines synthesized from glycidic acid pre‐precursors and retrospective search in German profiling database. Drug Testing and Analysis, 2020, 12. vsk, nro 1, s. 41–52. PubMed:31471943 doi:10.1002/dta.2686 ISSN 1942-7603 Artikkelin verkkoversio. (englanniksi)
Gimeno, P. ym.: A study of impurities in intermediates and 3,4-methylenedioxymethamphetamine (MDMA) samples produced via reductive amination routes. Forensic Science International, 2005, 155. vsk, nro 2-3, s. 141–157. PubMed:16226151 doi:10.1016/j.forsciint.2004.11.013 ISSN 0379-0738 Artikkelin verkkoversio. (englanniksi)
Levy, K. B. ym.: An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students. Substance use & misuse, 2005, 40. vsk, nro 9–10, s. 1427–1441. PubMed:16048826 doi:10.1081/JA-200066810 ISSN 1082-6084 Artikkelin verkkoversio. (englanniksi)
Brunt, T. M. ym.: Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology, 2012, 220. vsk, nro 4, s. 751–762. PubMed:21993879 doi:10.1007/s00213-011-2529-4 ISSN 1432-2072 Artikkelin verkkoversio. (englanniksi)
Allott, K. & Redman, J.: Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)? Neuroscience and Biobehavioral Reviews, 2007, 31. vsk, nro 3, s. 327–347. PubMed:17109962 doi:10.1016/j.neubiorev.2006.09.009 ISSN 0149-7634 Artikkelin verkkoversio. (englanniksi)
Baylen, C. A. & Rosenberg, H.: A review of the acute subjective effects of MDMA/ecstasy. Addiction, 2006, 101. vsk, nro 7, s. 933–947. PubMed:16771886 doi:10.1111/j.1360-0443.2006.01423.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Liechti, M. E. & Vollenweider, F. X.: Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Human Psychopharmacology: Clinical and Experimental, 2001, 16. vsk, nro 8, s. 589–598. doi:10.1002/hup.348 ISSN 1099-1077 Artikkelin verkkoversio. (englanniksi)
Mueller, F. ym.: Neuroimaging in moderate MDMA use: A systematic review. Neuroscience and Biobehavioral Reviews, 2016, nro 62, s. 21–34. PubMed:26746590 doi:10.1016/j.neubiorev.2015.12.010 ISSN 1873-7528 Artikkelin verkkoversio. (englanniksi)
Campbell, G. A. & Rosner, M. H.: The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Clinical Journal of the American Society of Nephrology, 2008, 3. vsk, nro 6, s. 1852–1860. PubMed:18684895 doi:10.2215/CJN.02080508 ISSN 1555-9041 Artikkelin verkkoversio. (englanniksi)
Armenian, P. ym.: Multiple MDMA (Ecstasy) overdoses at a rave event: a case series. Journal of Intensive Care Medicine, 2013, 28. vsk, nro 4, s. 252–258. PubMed:22640978 doi:10.1177/0885066612445982 ISSN 1525-1489 Artikkelin verkkoversio. (englanniksi)
RS Gable: Acute toxic effects of club drugs. Journal of Psychoactive Drugs, 2004, nro 3, s. 303–313. PubMed:15559678 doi:10.1080/02791072.2004.10400031 ISSN 0279-1072 Artikkelin verkkoversio. (englanniksi)
Gable, R. S.: Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction, 2004, 99. vsk, nro 6, s. 686–696. PubMed:15139867 doi:10.1111/j.1360-0443.2004.00744.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Silins, E. & Copeland, J. & Dillon, P.: Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk. The Australian and New Zealand Journal of Psychiatry, 2007, 41. vsk, nro 8, s. 649–655. PubMed:17620161 doi:10.1080/00048670701449237 ISSN 0004-8674 Artikkelin verkkoversio. (englanniksi)
Tancer, M. & Johanson, C.: The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology, 2007, 189. vsk, nro 4, s. 565–573. PubMed:17047932 doi:10.1007/s00213-006-0576-z ISSN 0033-3158 Artikkelin verkkoversio. (englanniksi)
Aguilar, M. A. & García-Pardo, M. P. & Parrott, A. C.: Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (’Ecstasy’). Brain Research, 2020, 78. vsk, s. 209-241. PubMed:31812710 doi:10.1016/j.brainres.2019.146556 ISSN 0006-8993 Artikkelin verkkoversio. (englanniksi)
Farré, M.: Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology, 2004, 173. vsk, nro 3-4, s. 364–375. PubMed:15071716 doi:10.1007/s00213-004-1789-7 ISSN 0033-3158 Artikkelin verkkoversio. (englanniksi)
Parrott, A. C.: Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. Journal of Psychopharmacology, 2005, 19. vsk, nro 1, s. 71–83. PubMed:15671132 doi:10.1177/0269881105048900 ISSN 0269-8811 Artikkelin verkkoversio. (englanniksi)
Cottler, L. B. & Leung, K. S. & Abdallah, A. B.: Test retest reliability of DSM-IV adopted criteria for MDMA abuse and dependence: A cross-national study. Addiction, 2009, 104. vsk, nro 10, s. 1679–1690. PubMed:19681802 doi:10.1111/j.1360-0443.2009.02649.x ISSN 0965-2140 Artikkelin verkkoversio. (englanniksi)
Sitte, H. H. & Freissmuth, M.: Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends in pharmacological sciences, 2015, 36. vsk, nro 1, s. 41–50. PubMed:25542076 doi:10.1016/j.tips.2014.11.006 ISSN 0165-6147 Artikkelin verkkoversio. (englanniksi)
Reyes-Parada, M. & Iturriaga-Vasquez, P. & Cassels, B. K.: Amphetamine derivatives as monoamine oxidase inhibitors. Frontiers in Pharmacology, 2020, 10. vsk. PubMed:32038257 doi:10.3389/fphar.2019.01590 ISSN 1663-9812 Artikkelin verkkoversio. (englanniksi)
Pitts, E. G. ym.: (±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA. Psychopharmacology, 2018, nro 2, s. 377–392. PubMed:29248945 doi:10.1007/s00213-017-4812-5 ISSN 1432-2072 Artikkelin verkkoversio. (englanniksi)
Simmler, L. D. ym.: In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1. The Journal of Pharmacology and Experimental Therapeutics, 2016, 357. vsk, nro 1, s. 134–144. PubMed:26791601 doi:10.1124/jpet.115.229765 ISSN 1521-0103 Artikkelin verkkoversio. (englanniksi)
Steuer, A. E. ym.: Impact of cytochrome P450 2D6 function on the chiral blood plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its phase I and II metabolites in humans. PLOS ONE, 2016, 11. vsk, nro 3, s. e0150955. doi:10.1371/journal.pone.0150955 ISSN 1932-6203 Artikkelin verkkoversio. (englanniksi)
Schwaninger, A. E. ym.: Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. Clinical chemistry, 2011, 57. vsk, nro 12, s. 1748–1756. PubMed:21980168 doi:10.1373/clinchem.2011.172254 ISSN 0009-9147 Artikkelin verkkoversio. (englanniksi)
Papaseit, E. ym.: Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV). Intensive Care Medicine, 2012, 38. vsk, nro 7, s. 1239–1240. doi:10.1007/s00134-012-2537-9 ISSN 1432-1238 Artikkelin verkkoversio. (englanniksi)

MDMA (Finnish Wikipedia)

ajconline.org (Global: low place; Finnish: low place)

apnews.com (Global: 129th place; Finnish: 643rd place)

asnjournals.org (Global: low place; Finnish: low place)

cjasn.asnjournals.org

aspetjournals.org (Global: 6,663rd place; Finnish: 2,918th place)

jpet.aspetjournals.org

benthamopen.com (Global: low place; Finnish: low place)

doi.org (Global: 2nd place; Finnish: 10th place)

dx.doi.org

erowid.org (Global: 3,887th place; Finnish: 839th place)

europa.eu (Global: 68th place; Finnish: 51st place)

emcdda.europa.eu

europepmc.org (Global: 8,929th place; Finnish: low place)

findlaw.com (Global: 1,478th place; Finnish: 6,146th place)

caselaw.findlaw.com

finlex.fi (Global: 3,070th place; Finnish: 17th place)

globaldrugsurvey.com (Global: low place; Finnish: low place)

jstor.org (Global: 26th place; Finnish: 312th place)

maps.org (Global: low place; Finnish: 5,059th place)

maps.org

bibliography.maps.org

mapscontent.s3-us-west-1.amazonaws.com (Global: low place; Finnish: low place)

mapseurope.eu (Global: low place; Finnish: low place)

nih.gov (Global: 4th place; Finnish: 12th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

northwestern.edu (Global: 2,302nd place; Finnish: 9,196th place)

scholarlycommons.law.northwestern.edu

psu.edu (Global: 207th place; Finnish: 1,082nd place)

citeseerx.ist.psu.edu

researchgate.net (Global: 120th place; Finnish: 243rd place)

rollsafe.org (Global: low place; Finnish: low place)

sagepub.com (Global: 731st place; Finnish: 767th place)

journals.sagepub.com

sciencedirect.com (Global: 149th place; Finnish: 237th place)

springer.com (Global: 274th place; Finnish: 418th place)

link.springer.com

tandfonline.com (Global: 507th place; Finnish: 559th place)

tietopyynto.fi (Global: low place; Finnish: 5,926th place)

unibas.ch (Global: low place; Finnish: low place)

edoc.unibas.ch

urn.fi (Global: 8,035th place; Finnish: 70th place)

web.archive.org (Global: 1st place; Finnish: 1st place)

wiley.com (Global: 222nd place; Finnish: 202nd place)

onlinelibrary.wiley.com

worldcat.org (Global: 5th place; Finnish: 9th place)

apnews.com (Global: 129^th place; Finnish: 643^rd place)

aspetjournals.org (Global: 6,663^rd place; Finnish: 2,918^th place)

doi.org (Global: 2^nd place; Finnish: 10^th place)

erowid.org (Global: 3,887^th place; Finnish: 839^th place)

europa.eu (Global: 68^th place; Finnish: 51^st place)

europepmc.org (Global: 8,929^th place; Finnish: low place)

findlaw.com (Global: 1,478^th place; Finnish: 6,146^th place)

finlex.fi (Global: 3,070^th place; Finnish: 17^th place)

jstor.org (Global: 26^th place; Finnish: 312^th place)

maps.org (Global: low place; Finnish: 5,059^th place)

nih.gov (Global: 4^th place; Finnish: 12^th place)

northwestern.edu (Global: 2,302^nd place; Finnish: 9,196^th place)

psu.edu (Global: 207^th place; Finnish: 1,082^nd place)

researchgate.net (Global: 120^th place; Finnish: 243^rd place)

sagepub.com (Global: 731^st place; Finnish: 767^th place)

sciencedirect.com (Global: 149^th place; Finnish: 237^th place)

springer.com (Global: 274^th place; Finnish: 418^th place)

tandfonline.com (Global: 507^th place; Finnish: 559^th place)

tietopyynto.fi (Global: low place; Finnish: 5,926^th place)

urn.fi (Global: 8,035^th place; Finnish: 70^th place)

web.archive.org (Global: 1^st place; Finnish: 1^st place)

wiley.com (Global: 222^nd place; Finnish: 202^nd place)

worldcat.org (Global: 5^th place; Finnish: 9^th place)